SANARIA INC.

Sanaria Inc. specializes in the development and manufacturing of biological products for infectious disease research, with a focused expertise in malaria parasite culture systems and clinical-stage vaccine development. The company produces asexual blood-stage malaria cultures and enriched late-stage gametocyte preparations under strict biospecimen standards, supporting both preclinical and Phase III clinical trials. Their technical capabilities span scalable cell culture methodologies, biological reagent formulation, and GMP-aligned production of live parasite-based therapeutics, positioning them as a niche provider of complex biological kits for global health research. Sanaria’s work integrates advanced parasitology, immunology, and bioprocessing to deliver reproducible, high-purity malaria reagents critical for vaccine evaluation and diagnostic validation. The contractor has delivered mission-critical biological and research services primarily to the Department of Health and Human Services, supporting public health initiatives in malaria control and vaccine development, and to the Department of Defense, where they have executed large-scale clinical trial support for infectious disease countermeasures. These engagements reflect a consistent pattern of partnership with agencies requiring high-containment biological manufacturing and translational research infrastructure. Sanaria’s core industry focus lies in Biological Product (Except Diagnostic) Manufacturing and Life Sciences R&D, where they operate at the intersection of parasitology and biopharmaceutical production. Their vertical specialization in malaria parasite culture systems distinguishes them in the global health biotech sector, serving as a key enabler for next-generation vaccine candidates and transmission-blocking interventions. Sanaria Inc. is a small business entity headquartered in Rockville, Maryland, with no formal government certifications on record. The company maintains a targeted presence in the federal life sciences market, leveraging its specialized manufacturing and research capabilities to serve mission-driven agencies focused on infectious disease preparedness and global health security.